Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
The DPT vaccine or DTP vaccine is a class of combination vaccine against three infectious diseases in humans: diphtheria, pertussis (whooping cough), and tetanus.
Market Analysis and Insights: Global DPT Vaccines Market
Due to the COVID-19 pandemic, the global DPT Vaccines market size is estimated to be worth US$ 5384.9 million in 2022 and is forecast to a readjusted size of US$ 6619.4 million by 2028 with a CAGR of 3.5% during the review period. Fully considering the economic change by this health crisis, DTaP accounting for % of the DPT Vaccines global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While 12 Months Below segment is altered to an % CAGR throughout this forecast period.
Global key DPT vaccines manufacturers include Sanofi Pasteur, GSK etc.The top 2 companies hold a share over 90%.Europe is the largest market, with a share about 34%, followed by North America and Asia-Pacific with the share about 27% and 25%.
Global DPT Vaccines Scope and Segment
DPT Vaccines market is segmented by Type and by Age. Players, stakeholders, and other participants in the global DPT Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Age for the period 2017-2028.
Segment by Type
DTaP
Tdap
DTwP
Segment by Age
12 Months Below
12 Months Above
By Company
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Market Analysis and Insights: Global DPT Vaccines Market
Due to the COVID-19 pandemic, the global DPT Vaccines market size is estimated to be worth US$ 5384.9 million in 2022 and is forecast to a readjusted size of US$ 6619.4 million by 2028 with a CAGR of 3.5% during the review period. Fully considering the economic change by this health crisis, DTaP accounting for % of the DPT Vaccines global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While 12 Months Below segment is altered to an % CAGR throughout this forecast period.
Global key DPT vaccines manufacturers include Sanofi Pasteur, GSK etc.The top 2 companies hold a share over 90%.Europe is the largest market, with a share about 34%, followed by North America and Asia-Pacific with the share about 27% and 25%.
Global DPT Vaccines Scope and Segment
DPT Vaccines market is segmented by Type and by Age. Players, stakeholders, and other participants in the global DPT Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Age for the period 2017-2028.
Segment by Type
DTaP
Tdap
DTwP
Segment by Age
12 Months Below
12 Months Above
By Company
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
